CollPlant Biotechnologies (CLGN) Return on Capital Employed (2018 - 2025)
CollPlant Biotechnologies (CLGN) reported Return on Capital Employed of 18.75% for Q4 2025, down 2217.0% on a YoY basis from 0.89% in Q4 2024, and up 7.26% quarter-over-quarter from 20.22% in Q3 2025.
CollPlant Biotechnologies (CLGN) Return on Capital Employed (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Return on Capital Employed for 8 years, with the latest figure at 18.75% in Q4 2025.
- For the quarter ending Q4 2025, Return on Capital Employed fell 2217.0% year-over-year to 18.75%; the trailing twelve-month figure through Dec 2025 stood at 18.75% (down 2217.0% YoY), and the FY2025 full-year result was 95.09%, down 2152.0% from the prior year.
- Return on Capital Employed for Q4 2025 stood at 18.75%, up from 20.22% in the prior quarter.
- The five-year high for Return on Capital Employed was 121.52% in Q1 2021, with the low at 61.65% in Q2 2025.
- Historically, Return on Capital Employed has averaged 6.81% across 5 years, with a median of 8.93% in 2024.
- Annual changes were most pronounced in 2021 — Return on Capital Employed jumped 16812 bps — and 2022, when it sank 13459 bps.
- CollPlant Biotechnologies' Return on Capital Employed stood at 0.13% in 2021, then sank by 20257 bps to 26.52% in 2022, then jumped by 87 bps to 3.43% in 2023, then surged by 200 bps to 3.42% in 2024, then sank by 648 bps to 18.75% in 2025.
- The last three Return on Capital Employed figures came in at 18.75% (Q4 2025), 20.22% (Q3 2025), and 61.65% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -107.40% |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -50.43% |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -18.75% |
| Sep 30, 2025 | -20.22% |
| Jun 30, 2025 | -61.65% |
| Mar 31, 2025 | -36.95% |
| Dec 31, 2024 | 3.42% |
| Sep 30, 2024 | -8.56% |
| Jun 30, 2024 | -9.30% |
| Mar 31, 2024 | 2.46% |
| Dec 31, 2023 | -3.43% |
| Sep 30, 2023 | -0.45% |
| Jun 30, 2023 | 0.14% |
| Mar 31, 2023 | -28.99% |
| Dec 31, 2022 | -26.52% |
| Sep 30, 2022 | -21.64% |
| Jun 30, 2022 | -16.55% |
| Mar 31, 2022 | -13.08% |
| Dec 31, 2021 | 0.13% |
| Sep 30, 2021 | -3.33% |
| Jun 30, 2021 | 5.56% |
| Mar 31, 2021 | 121.52% |